...
首页> 外文期刊>Cell Reports >PLK1 Signaling in Breast Cancer Cells Cooperates with Estrogen Receptor-Dependent Gene Transcription
【24h】

PLK1 Signaling in Breast Cancer Cells Cooperates with Estrogen Receptor-Dependent Gene Transcription

机译:乳腺癌细胞中的PLK1信号与雌激素受体依赖性基因转录合作。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Polo-like kinase 1 (PLK1) is a key regulator of cell division and is overexpressed in many types of human cancers. Compared to its well-characterized role in mitosis, little is known about PLK1 functions in interphase. Here, we report that PLK1 mediates estrogen receptor (ER)-regulated gene transcription in human breast cancer cells. PLK1 interacts with ER and is recruited to ER cis-elements on chromatin. PLK1-coactivated genes included classical ER target genes such as Ps2, Wisp2, and Serpina3 and were enriched in developmental and tumor-suppressive functions. Performing large-scale phosphoproteomics of estradiol-treated MCF7 cells in the presence or absence of the specific PLK1 inhibitor BI2536, we identified several PLK1 end targets involved in transcription, including the histone H3K4 trimethylase MLL2, the function of which on ER target genes was impaired by PLK1 inhibition. Our results propose a mechanism for the tumor-suppressive role of PLK1 in mammals as an interphase transcriptional regulator.
机译:Polo样激酶1(PLK1)是细胞分裂的关键调节剂,在许多类型的人类癌症中均过表达。相比其在有丝分裂中已被很好地描述的作用,人们对PLK1在相间的功能了解甚少。在这里,我们报道PLK1介导人类乳腺癌细胞中雌激素受体(ER)调控的基因转录。 PLK1与ER相互作用,并被募集到染色质的ER顺式元件上。 PLK1共激活的基因包括经典的ER靶基因,例如Ps2,Wisp2和Serpina3,并且在发育和肿瘤抑制功能方面很丰富。在存在或不存在特定PLK1抑制剂BI2536的情况下,进行雌二醇处理的MCF7细胞的大规模磷酸化蛋白质组学,我们确定了参与转录的几个PLK1末端靶标,包括组蛋白H3K4三甲基化酶MLL2,其对ER靶标基因的功能受到损害通过PLK1抑制。我们的研究结果提出了PLK1在哺乳动物中作为相间转录调节因子的肿瘤抑制作用的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号